Ahmed Nabil
Overview
Explore the profile of Ahmed Nabil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farid A, Ooda A, Nabil A, Nasser A, Ahmed E, Ali F, et al.
J Nanobiotechnology
. 2025 Mar;
23(1):210.
PMID: 40082962
No abstract available.
2.
Shalaby M, Abdel-Reheim E, N Almanaa T, Alhaber L, Nabil A, Ahmed O, et al.
Regen Ther
. 2024 Dec;
28:1-11.
PMID: 39678398
Cell-based therapy is a new direction of treatment of diseases such as type 1 diabetes mellitus (T1DM); but unfortunately, its severe side effects include immunogenicity and tumor development. Using Mesenchymal...
3.
Nabil A, Abdel-Motaal M, Hassan A, Elshemy M, Asem M, Elwan M, et al.
RSC Adv
. 2024 Nov;
14(51):37960-37974.
PMID: 39610815
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related morbidity worldwide. Sorafenib is a first-line drug for the treatment of HCC, however, it is reported to cause serious...
4.
Yoshihara E, Nabil A, Iijima M, Ebara M
ACS Omega
. 2024 May;
9(20):22043-22050.
PMID: 38799371
Early diagnosis of infectious diseases is still challenging particularly in a nonlaboratory environment or limited resources areas. Thus, sensitive, inexpensive, and easily handled diagnostic approaches are required. The lateral flow...
5.
Madbouly N, Ooda A, Nabil A, Nasser A, Ahmed E, Ali F, et al.
Inflammopharmacology
. 2024 Apr;
32(4):2629-2645.
PMID: 38662181
The development of nanoparticles (NPs) with active components with upgraded stability, and prolonged release helps in enhanced tissue regeneration. In addition, NPs are feasible strategy to boost antibiotic effectiveness and...
6.
Nabil A, Abd Halim Hafez K, Rizk A, Abu Taleb A, Emad R
J Orthop
. 2024 Mar;
53:7-12.
PMID: 38450063
Objective: The purpose of this randomised controlled trial was to assess the effect on knee function and stabilising effectiveness of lateral extra-articular tenodesis (LET) in anterior cruciate ligament (ACL) restoration....
7.
Lee G, Iwase T, Matsumoto S, Nabil A, Ebara M
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003225
Background: Apoptotic cells' phosphoserine (PS) groups have a significant immunosuppressive effect. They inhibit proinflammatory signals by interacting with various immune cells, including macrophages, dendritic cells, and CD4 cells. Previously, we...
8.
Lee G, Nabil A, Kwon O, Ebara M
Biomater Sci
. 2023 Oct;
11(24):7897-7908.
PMID: 37906511
Inflammatory M1 macrophages create a hostile environment that impedes wound healing. Phosphoserine (PS) is a naturally occurring immunosuppressive molecule capable of polarizing macrophages from an inflammatory phenotype (M1) to an...
9.
Farid A, Ooda A, Nabil A, Nasser A, Ahmed E, Ali F, et al.
J Nanobiotechnology
. 2023 Oct;
21(1):373.
PMID: 37828599
Background: Usually, wounds recover in four to six weeks. Wounds that take longer time than this to heal are referred to as chronic wounds. Impaired healing can be caused by...
10.
Chen L, Nabil A, Fujisawa N, Oe E, Li K, Ebara M
J Control Release
. 2023 Oct;
363:550-561.
PMID: 37804880
Anticancer drug resistance invariably emerges and poses a significant barrier to curative therapy for various breast cancers. This results in a lack of satisfactory therapeutic medicine for cancer treatment. Herein,...